Orange County Labs INC.

Orange County Labs INC. was paid $861K by Medicaid between Jan 2018 and Oct 2023, across 68 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#198 of 561

Median peer was paid$222K

This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	5,738	$6K
2019	386	$253.34
2020	5,432	$45K
2021	17,698	$583K
2022	6,887	$219K
2023	1,169	$8K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	74%	10,123	4,056	$640K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	20%	9,639	3,905	$176K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,040	897	$8K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	<1%	107	106	$8K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	368	162	$7K
87150		<1%	668	580	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,805	1,443	$5K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	710	585	$2K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	115	112	$1K
87507		<1%	935	814	$867.78
86769		<1%	64	57	$716.38
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	357	343	$652.84

56 more codes

87486		<1%	1,257	$464.25
87581		<1%	1,257	$464.25
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	224	$396.39
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	639	$375.32
87640		<1%	639	$375.32
87634		<1%	230	$308.72
87641		<1%	610	$295.48
82150		<1%	54	$265.88
87631		<1%	189	$242.45
84436		<1%	210	$224.16
84480		<1%	191	$201.44
87498		<1%	229	$160.95
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	193	$154.84
87541		<1%	255	$154.31
84443	Thyroid stimulating hormone (TSH)	<1%	208	$145.17
87500		<1%	325	$104.84
80053	Comprehensive metabolic panel	<1%	266	$96.05
83036	Hemoglobin; glycosylated (A1C)	<1%	284	$94.93
82670		<1%	70	$76.86
84479		<1%	29	$73.84
80061	Lipid panel	<1%	180	$73.75
82627		<1%	54	$61.07
84144		<1%	56	$57.10
83540		<1%	19	$51.48
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	278	$51.14
84403		<1%	74	$45.14
84402		<1%	69	$44.82
82607		<1%	14	$41.48
82746		<1%	46	$40.58
84270		<1%	91	$37.06
84146		<1%	44	$33.88
83002		<1%	14	$32.44
83700		<1%	59	$32.13
84481		<1%	204	$29.64
82533		<1%	54	$28.70
83735		<1%	202	$23.84
84439		<1%	237	$23.65
86141		<1%	163	$22.16
84154		<1%	29	$16.19
84550		<1%	194	$12.46
83690		<1%	42	$12.04
81001		<1%	313	$8.80
82248		<1%	55	$8.74
84100		<1%	56	$8.34
82570		<1%	538	$4.22
86431		0%	90	$0.00
86038		0%	89	$0.00
86039		0%	60	$0.00
86225		0%	79	$0.00
86160		0%	80	$0.00
82043		0%	133	$0.00
36415	Collection of venous blood by venipuncture	0%	148	$0.00
86376		0%	163	$0.00
85651		0%	17	$0.00
85652		0%	37	$0.00
81015		0%	39	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRAMSEY, JAMES (OWNER)

Parent organizationORANGE COUNTY LABS INC.